Is BioCryst Pharmaceuticals, Inc. (BCRX) a Buy, Sell, or Hold?
BioCryst Pharmaceuticals, Inc.
NASDAQ:BCRX
$9.41 USD
-$0.33 (-3.39%)
- Volume
- 6.68M
- Average Volume
- 5.05M
- Market Capitalization
- $1.98B
- P/E Ratio
- -5.44
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.22
- Year Low
- $6.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.53%
Investors Holding
12
change: -303 | last: 315
Increased Positions
7
change: -185 | last: 192
Reduced Positions
2
change: -73 | last: 75
New Positions
3
change: -70 | last: 73
Sold Positions
294
change: 247 | last: 47
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -45.2183 | last: 0.4522
Total Invested
12.61M
BCRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.80 | 209.89M | $1.64B | $89.74M | $438.87M | $1.99B |
| 2024-12-31 | $7.52 | 206.7M | $1.55B | $104.92M | $841.42M | $2.29B |
| 2023-12-31 | $5.99 | 192.2M | $1.15B | $110.64M | $825.15M | $1.87B |
| 2022-12-31 | $11.48 | 185.91M | $2.13B | $304.77M | $741.45M | $2.57B |
| 2021-12-31 | $13.85 | 179.12M | $2.48B | $504.39M | $593.24M | $2.57B |
| 2020-12-31 | $7.45 | 167.27M | $1.25B | $272.13M | $279.5M | $1.25B |
| 2019-12-31 | $3.45 | 115.6M | $398.82M | $114.17M | $84.65M | $369.3M |
| 2018-12-31 | $8.07 | 103.18M | $832.7M | $26.73M | $61.82M | $867.79M |
| 2017-12-31 | $4.91 | 84.45M | $414.65M | $50.28M | $54.72M | $419.09M |
| 2016-12-31 | $6.33 | 73.7M | $466.51M | $22.1M | $53.72M | $498.13M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9.52 | 242.26M | $2.31B | $172.44M | $858.08M | $2.99B |
| 2025-12-31 | $7.80 | 210.97M | $1.65B | $89.74M | $438.87M | $1.99B |
| 2025-09-30 | $7.59 | 210.18M | $1.6B | $84.08M | $683.11M | $2.19B |
| 2025-06-30 | $8.96 | 209.52M | $1.88B | $88.03M | $703.18M | $2.49B |
| 2025-03-31 | $7.50 | 208.88M | $1.57B | $105.48M | $829.29M | $2.29B |
| 2024-12-31 | $7.52 | 207.38M | $1.56B | $104.92M | $841.42M | $2.3B |
| 2024-09-30 | $7.60 | 206.9M | $1.57B | $97.65M | $842.14M | $2.32B |
| 2024-06-30 | $6.67 | 206.42M | $1.38B | $78.41M | $821.67M | $2.12B |
| 2024-03-31 | $5.05 | 206.06M | $1.04B | $84.33M | $826.88M | $1.78B |
| 2023-12-31 | $5.99 | 201.41M | $1.21B | $110.64M | $825.15M | $1.92B |
| 2023-09-30 | $7.08 | 189.64M | $1.34B | $150.9M | $845.43M | $2.04B |
| 2023-06-30 | $7.04 | 189.12M | $1.33B | $146.22M | $827.63M | $2.01B |